Austin Murata

Array ( [id] => 5760114 [patent_doc_number] => 20060211059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods of improving screening, diagnosis and staging of prostate cancer using serum testosterone' [patent_app_type] => utility [patent_app_number] => 11/377097 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20990 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211059.pdf [firstpage_image] =>[orig_patent_app_number] => 11377097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699553 [patent_doc_number] => 20060216237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Inhibition of angiogenesis and tumor development by IGFBP-4' [patent_app_type] => utility [patent_app_number] => 11/372367 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11328 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216237.pdf [firstpage_image] =>[orig_patent_app_number] => 11372367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921267 [patent_doc_number] => 20060239965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Extracellular matrix binding chimeric proteins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/365073 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18071 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239965.pdf [firstpage_image] =>[orig_patent_app_number] => 11365073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784256 [patent_doc_number] => 20060204474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Treatment of epithelial layer lesions' [patent_app_type] => utility [patent_app_number] => 11/364874 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4954 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204474.pdf [firstpage_image] =>[orig_patent_app_number] => 11364874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850618 [patent_doc_number] => 20060233809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Method for treating prostate conditions' [patent_app_type] => utility [patent_app_number] => 11/350171 [patent_app_country] => US [patent_app_date] => 2006-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7822 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233809.pdf [firstpage_image] =>[orig_patent_app_number] => 11350171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12962644 [patent_doc_number] => 09873730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Method for improving antibody [patent_app_type] => utility [patent_app_number] => 11/815838 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 9467 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11815838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705218 [patent_doc_number] => 20060194266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Use of protein RLA-0 as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/348889 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7760 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194266.pdf [firstpage_image] =>[orig_patent_app_number] => 11348889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682962 [patent_doc_number] => 20060199232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Use of protein PSE3 as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/348950 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7541 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199232.pdf [firstpage_image] =>[orig_patent_app_number] => 11348950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619417 [patent_doc_number] => 20060188950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Use of protein spee as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/348932 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7555 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188950.pdf [firstpage_image] =>[orig_patent_app_number] => 11348932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619416 [patent_doc_number] => 20060188949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Use of protein PLST as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/348841 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7404 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188949.pdf [firstpage_image] =>[orig_patent_app_number] => 11348841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705181 [patent_doc_number] => 20060194229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Cancer markers and detection methods' [patent_app_type] => utility [patent_app_number] => 11/339052 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16751 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194229.pdf [firstpage_image] =>[orig_patent_app_number] => 11339052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643223 [patent_doc_number] => 20060281678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Novel inhibitor of angiogenesis, tumor progression, and metastasis targeting ras signalling pathway' [patent_app_type] => utility [patent_app_number] => 11/321186 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9863 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281678.pdf [firstpage_image] =>[orig_patent_app_number] => 11321186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927006 [patent_doc_number] => 20080166369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Cancer Vaccine Preparation' [patent_app_type] => utility [patent_app_number] => 11/722019 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3758 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166369.pdf [firstpage_image] =>[orig_patent_app_number] => 11722019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455506 [patent_doc_number] => 07892750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-02-22 [patent_title] => 'Cathepsin E as a marker of colon cancer' [patent_app_type] => utility [patent_app_number] => 11/312780 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4793 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892750.pdf [firstpage_image] =>[orig_patent_app_number] => 11312780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678537 [patent_doc_number] => 20060183893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Nucleic acids for apoptosis of cancer cells' [patent_app_type] => utility [patent_app_number] => 11/311594 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183893.pdf [firstpage_image] =>[orig_patent_app_number] => 11311594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872839 [patent_doc_number] => 20060165653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Use of Fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders' [patent_app_type] => utility [patent_app_number] => 11/305843 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22698 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165653.pdf [firstpage_image] =>[orig_patent_app_number] => 11305843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899753 [patent_doc_number] => 20080119367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Prognosis of Renal Cell Carcinoma' [patent_app_type] => utility [patent_app_number] => 11/721794 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9875 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119367.pdf [firstpage_image] =>[orig_patent_app_number] => 11721794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912873 [patent_doc_number] => 20060127935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Identification and use of prognostic and predictive markers in cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/300869 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 5888 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127935.pdf [firstpage_image] =>[orig_patent_app_number] => 11300869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949390 [patent_doc_number] => 20080305516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Method of Producing Antibodies' [patent_app_type] => utility [patent_app_number] => 11/720028 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12705 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305516.pdf [firstpage_image] =>[orig_patent_app_number] => 11720028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613934 [patent_doc_number] => 20060115862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Anti-tenascin monoclonal antibody immunoassays and diagnostic kits' [patent_app_type] => utility [patent_app_number] => 11/282117 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6160 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115862.pdf [firstpage_image] =>[orig_patent_app_number] => 11282117 [rel_patent_id] =>[rel_patent_doc_number] =>)